Chemotherapy and Radiation Following Pancreatic Surgery
Status:
Completed
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
To describe the overall survival and disease-free survival in pancreatic cancer patients
treated with adjuvant chemoradiation with cisplatin, continuous infusion 5FU and interferon
alpha followed by gemcitabine.
To describe the toxicities associated with adjuvant chemoradiation with cisplatin. 5FU and
interferon alfa followed by gemcitabine in patients with pancreatic cancers.